Eilis Quinn

Eilis Quinn is an accomplished professional with extensive experience in the pharmaceutical industry, currently serving as General Manager for Australia and New Zealand at Jazz Pharmaceuticals since August 2022. Prior to this role, Eilis held various senior leadership positions at Vertex Pharmaceuticals from 2012 to April 2022, including Senior Director Pipeline Global and Country Manager and Managing Director for Australia and New Zealand. Eilis began a career at Genzyme, contributing as Business Unit Director for Endocrinology, Nuclear Medicine (Oncology), and Renal, and held multiple roles within Genzyme Europe and Genzyme Europe BV, including Associate Director and European Senior Product Manager. Eilis Quinn possesses advanced degrees in Biotechnology, Law and Ethics (MA), Biomedical Sciences (MSc), and a Bachelor's in Biomedical Sciences (BSc), alongside a Diploma in Business Management from The University of Sheffield, University of Westminster, Ulster University, and Sheffield, respectively.